Fernanda Bernadelli De Vito

6PUBLICATIONS
24CO-AUTHORS
HaematologyPredictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Developmental genetics (incl. sex determination)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 03, 2026
What is the best approach to blood transfusion in sickle cell disease? A scientometric analysis and literature review.

Christiane Ruffato Carminati, Lucas Fernandes Ananias, Saulo Fernando Moreira da Silva

|Sep 28, 2024
COVID-19 Inflammatory Syndrome: Lessons from TNFRI and CRP about the Risk of Death in Severe Disease.

Thaís Soares Farnesi-de-Assunção, Ana Carolina de Morais Oliveira-Scussel, Wellington Francisco Rodrigues

|Nov 22, 2020
RhoA/ROCKs signaling is increased by treatment with TKI-258 and leads to increased apoptosis in SCC-4 oral squamous cell carcinoma cell line.

Anna Cecília Dias Maciel Carneiro, Fernanda Bernadelli De Vito, Helio Moraes-Souza

|Nov 04, 2020
Identification of <i>Leishmania infantum</i> in blood donors from endemic regions for visceral leishmaniasis.

Loren Queli Pereira, Márcia Maria Ferreira-Silva, Cristhianne Molinero Andrade Ratkevicius

|Aug 14, 2019
Male sickle cell patients, compensated transpubertal hypogonadism and normal final growth.

Paulo Roberto Juliano Martins, Fernanda Bernadelli De Vito, Gláucia Aparecida Domingos Resende

|Jul 07, 2017
Evaluation of the cytotoxic response mediated by perforin and granzyme B in patients with non-Hodgkin lymphoma.

Bruna Maria Bereta Souza, Fernanda Bernadelli De Vito, Marianna Licati Calado

Pageof 1